Marshall Wace, LLP Ptc Therapeutics, Inc. Put Options Transaction History
Marshall Wace, LLP
- $72.2 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PTCT
# of Institutions
215Shares Held
79.2MCall Options Held
122KPut Options Held
212K-
Vanguard Group Inc Valley Forge, PA8.97MShares$301 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.21MShares$276 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$261 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$248 Million3.78% of portfolio
-
Armistice Capital, LLC New York, NY6.96MShares$234 Million2.77% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $2.4B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...